KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Intangibles: 2013-2021

Historic Intangibles for Novavax (NVAX) over the last 9 years, with Dec 2021 value amounting to $4.8 million.

  • Novavax's Intangibles rose 68.21% to $8.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $8.5 million, marking a year-over-year increase of 68.21%. This contributed to the annual value of $4.8 million for FY2021, which is 16.68% down from last year.
  • According to the latest figures from FY2021, Novavax's Intangibles is $4.8 million, which was down 16.68% from $5.7 million recorded in FY2020.
  • Novavax's 5-year Intangibles high stood at $7.9 million for FY2017, and its period low was $4.8 million during FY2021.
  • Its 3-year average for Intangibles is $5.4 million, with a median of $5.6 million in 2019.
  • As far as peak fluctuations go, Novavax's Intangibles declined by 16.92% in 2018, and later grew by 2.58% in 2020.
  • Novavax's Intangibles (Yearly) stood at $7.9 million in 2017, then dropped by 16.92% to $6.5 million in 2018, then decreased by 14.68% to $5.6 million in 2019, then climbed by 2.58% to $5.7 million in 2020, then decreased by 16.68% to $4.8 million in 2021.